SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-066327
Filing Date
2024-08-08
Accepted
2024-08-08 07:06:48
Documents
24
Period of Report
2024-08-08
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0210840-8k_aldeyra.htm   iXBRL 8-K 26088
2 ALDEYRA THERAPEUTICS, INC. PRESENTATION DATED AUGUST 8, 2024 ea021084001ex99-1_aldeyra.htm EX-99.1 17920
3 ALDEYRA THERAPEUTICS, INC. PRESS RELEASE DATED AUGUST 8, 2024 ea021084001ex99-2_aldeyra.htm EX-99.2 18819
4 GRAPHIC ex99-1_001.jpg GRAPHIC 192015
5 GRAPHIC ex99-1_002.jpg GRAPHIC 639295
6 GRAPHIC ex99-1_003.jpg GRAPHIC 298558
7 GRAPHIC ex99-1_004.jpg GRAPHIC 241998
8 GRAPHIC ex99-1_005.jpg GRAPHIC 227833
9 GRAPHIC ex99-1_006.jpg GRAPHIC 340919
10 GRAPHIC ex99-1_007.jpg GRAPHIC 287156
11 GRAPHIC ex99-1_008.jpg GRAPHIC 264304
12 GRAPHIC ex99-2_001.jpg GRAPHIC 3720
  Complete submission text file 0001213900-24-066327.txt   3688347

Data Files

Seq Description Document Type Size
13 XBRL SCHEMA FILE aldx-20240808.xsd EX-101.SCH 3015
14 XBRL LABEL FILE aldx-20240808_lab.xml EX-101.LAB 34240
15 XBRL PRESENTATION FILE aldx-20240808_pre.xml EX-101.PRE 22359
26 EXTRACTED XBRL INSTANCE DOCUMENT ea0210840-8k_aldeyra_htm.xml XML 3688
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36332 | Film No.: 241185984
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)